Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:01:56.468Z.
Calculation as of: 2026-10-06T18:01:56.468Z.
Quote observation: 2026-10-06T18:00:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6caa0376099c5ebdf209f9b018955c4d65987c3db8176dc1b5ff0a1c5aca19bf
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Bright Minds Biosciences Inc.
Market Cap
$476.39M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$474.17M
Operating Cash Flow Yield
N/A
TTM Avg
0.90%
3Y Avg
0.90%
5Y Avg
0.90%
Market Cap
$475.20M
Operating Cash Flow Yield
N/A
TTM Avg
18.97%
3Y Avg
18.89%
5Y Avg
14.32%
Market Cap
$474.59M
Operating Cash Flow Yield
0.51%
TTM Avg
0.89%
3Y Avg
1.82%
5Y Avg
1.82%
Market Cap
$472.55M
Operating Cash Flow Yield
N/A
TTM Avg
4.04%
3Y Avg
4.04%
5Y Avg
4.04%
Market Cap
$470.79M
Operating Cash Flow Yield
7.65%
TTM Avg
6.58%
3Y Avg
6.94%
5Y Avg
6.76%
Market Cap
$467.47M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$486.09M
Operating Cash Flow Yield
8.47%
TTM Avg
13.05%
3Y Avg
17.35%
5Y Avg
16.73%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $476.39M | N/A | N/A | N/A | N/A |
| Alpha Teknova, Inc. (TKNO)vs › | $474.17M | N/A | 0.90% | 0.90% | 0.90% |
| Arvinas, Inc. (ARVN)vs › | $475.20M | N/A | 18.97% | 18.89% | 14.32% |
| Cerus Corporation (CERS)vs › | $474.59M | 0.51% | 0.89% | 1.82% | 1.82% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $472.55M | N/A | 4.04% | 4.04% | 4.04% |
| Kamada Ltd. (KMDA)vs › | $470.79M | 7.65% | 6.58% | 6.94% | 6.76% |
| Sight Sciences, Inc. (SGHT)vs › | $467.47M | N/A | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.09M | 8.47% | 13.05% | 17.35% | 16.73% |
| Evolus, Inc. (EOLS)vs › | $486.50M | N/A | N/A | N/A | N/A |
| Oculis Holding AG (OCS)vs › | $495.97M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
